Company profile

Vesalius Cardiovascular Inc.

Transfemoral Mitral Valve Repair Solution for Degenerative MR Patients.

Industry
Biotechnology Research
Employees
10
Headquarters
Vancouver, British Columbia
Founded
2016
LinkedIn followers
1,704
Office locations
1

Vesalius Cardiovascular Inc. company summary

Vesalius Cardiovascular Inc. is a company in the Biotechnology Research industry, headquartered in Vancouver, British Columbia, founded in 2016. On LinkedIn the company has around 10 employees and 1,704 followers. Its listed specialties include medical devices, biotech, Catheter, biomedical.

What technology does Vesalius Cardiovascular Inc. use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Vesalius Cardiovascular Inc.

Vesalius Cardiovascular is a Canadian medical device company founded in 2016 in Vancouver, Canada. The company specializes in designing and developing biomedical devices for the treatment of cardiovascular disease, specifically mitral valve regurgitation (MR). We are clinical. Our devices is introduced percutaneously (transfemoral/transseptal) to the heart, eliminating the need for open heart surgery and the related risks. The procedure can be performed by a Cardiovascular Interventionalist (Cardiologist or Cardiac Surgeon). Vesalius Cardiovascular is the result of several years of intensive private research and investigation, and advanced biomedical engineering. The inventor behind Vesalius Cardiovascular is Dr. Peter Skarsgard, a Vancouver-based Cardiac Surgeon, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. Vesalius Cardiovascular has developed a biomedical device that can be introduced percutaneously (transfemoral/transseptal) to the heart, for the treatment of Degenerative MR (DMR). The principles of surgical mitral valve repair are utilized, but sternotomy, heart-lung bypass, and cardiac arrest - components of an open heart operation - are not required.

Specialties

medical devicesbiotechCatheterbiomedical

Where is Vesalius Cardiovascular Inc. located?

Vesalius Cardiovascular Inc. lists 1 location.

Vancouver, British Columbia V5Y3W2, CAHQ
210 W Broadway

Compare companies similar to Vesalius Cardiovascular Inc.

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Vesalius Cardiovascular Inc.
vesaliuscardio.com
Biotechnology Research102016Vancouver, British Columbia
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Vesalius Cardiovascular Inc.

What does Vesalius Cardiovascular Inc. do?

Vesalius Cardiovascular is a Canadian medical device company founded in 2016 in Vancouver, Canada. The company specializes in designing and developing biomedical devices for the treatment of cardiovascular disease, specifically mitral valve regurgitation (MR). We are clinical. Our devices is introduced percutaneously (transfemoral/transseptal) to the heart, eliminating the need for open heart surgery and the related risks. The procedure can be performed by a Cardiovascular Interventionalist (Cardiologist or Cardiac Surgeon). Vesalius Cardiovascular is the result of several years of intensive private research and investigation, and advanced biomedical engineering. The inventor behind Vesalius Cardiovascular is Dr. Peter Skarsgard, a Vancouver-based Cardiac Surgeon, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. Vesalius Cardiovascular has developed a biomedical device that can be introduced percutaneously (transfemoral/transseptal) to the heart, for the treatment of Degenerative MR (DMR). The principles of surgical mitral valve repair are utilized, but sternotomy, heart-lung bypass, and cardiac arrest - components of an open heart operation - are not required.

How many employees does Vesalius Cardiovascular Inc. have?

Vesalius Cardiovascular Inc. has around 10 employees on LinkedIn.

Where is Vesalius Cardiovascular Inc. headquartered?

Vesalius Cardiovascular Inc. is headquartered in Vancouver, British Columbia.

When was Vesalius Cardiovascular Inc. founded?

Vesalius Cardiovascular Inc. was founded in 2016.

Build a lead list from companies like Vesalius Cardiovascular Inc.

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.